Multimodal analysis of gene expression from postmortem brains and blood identifies synaptic vesicle trafficking genes to be associated with Parkinson's disease

OBJECTIVE We aimed to identify key susceptibility gene targets in multiple datasets generated from postmortem brains and blood of Parkinson's disease (PD) patients and healthy controls (HC). METHODS We performed a multitiered analysis to integrate the gene expression data using multiple-gene chips from 244 human postmortem tissues. We identified hub node genes in the highly PD-related consensus module by constructing protein-protein interaction (PPI) networks. Next, we validated the top four interacting genes in 238 subjects (90 sporadic PD, 125 HC and 23 Parkinson's Plus Syndrome (PPS)). Utilizing multinomial logistic regression analysis (MLRA) and receiver operating characteristic (ROC), we analyzed the risk factors and diagnostic power for discriminating PD from HC and PPS. RESULTS We identified 1333 genes that were significantly different between PD and HCs based on seven microarray datasets. The identified MEturquoise module is related to synaptic vesicle trafficking (SVT) dysfunction in PD (P < 0.05), and PPI analysis revealed that SVT genes PPP2CA, SYNJ1, NSF and PPP3CB were the top four hub node genes in MEturquoise (P < 0.001). The levels of these four genes in PD postmortem brains were lower than those in HC brains. We found lower blood levels of PPP2CA, SYNJ1 and NSF in PD compared with HC, and lower SYNJ1 in PD compared with PPS (P < 0.05). SYNJ1, negatively correlated to PD severity, displayed an excellent power to discriminating PD from HC and PPS. CONCLUSIONS This study highlights that SVT genes, especially SYNJ1, may be promising markers in discriminating PD from HCs and PPS.

[1]  A. Korczyn,et al.  Can Biomarkers Help the Early Diagnosis of Parkinson’s Disease? , 2017, Neuroscience Bulletin.

[2]  Lin Shi,et al.  Plasma Lipoprotein-associated Phospholipase A2 and Superoxide Dismutase are Independent Predicators of Cognitive Impairment in Cerebral Small Vessel Disease Patients: Diagnosis and Assessment , 2019, Aging and disease.

[3]  E. Sidransky,et al.  Glucocerebrosidase and its relevance to Parkinson disease , 2019, Molecular Neurodegeneration.

[4]  Steve Horvath,et al.  WGCNA: an R package for weighted correlation network analysis , 2008, BMC Bioinformatics.

[5]  P Sandroni,et al.  Second consensus statement on the diagnosis of multiple system atrophy , 2008, Neurology.

[6]  D. McCormick,et al.  Essential Role of Phosphoinositide Metabolism in Synaptic Vesicle Recycling , 1999, Cell.

[7]  P. Bickford,et al.  Astaxanthin supplementation modulates cognitive function and synaptic plasticity in young and aged mice , 2019, GeroScience.

[8]  J. Rothman,et al.  A multisubunit particle implicated in membrane fusion , 1992, The Journal of cell biology.

[9]  Z. Yue,et al.  Crosstalk between presynaptic trafficking and autophagy in Parkinson's disease , 2019, Neurobiology of Disease.

[10]  Peter Langfelder,et al.  When Is Hub Gene Selection Better than Standard Meta-Analysis? , 2013, PloS one.

[11]  A. Szybińska,et al.  P53 Dysfunction in Neurodegenerative Diseases - The Cause or Effect of Pathological Changes? , 2017, Aging and disease.

[12]  Jia-wei Zhou,et al.  Comparing levocardia and dextrocardia in fetuses with heterotaxy syndrome: prenatal features, clinical significance and outcomes , 2017, BMC Pregnancy and Childbirth.

[13]  Yongquan Lu,et al.  Leucine Carboxyl Methyltransferase Downregulation and Protein Phosphatase Methylesterase Upregulation Contribute Toward the Inhibition of Protein Phosphatase 2A by α-Synuclein , 2018, Front. Aging Neurosci..

[14]  R. Shukla,et al.  AT2R Activation Prevents Microglia Pro-inflammatory Activation in a NOX-Dependent Manner: Inhibition of PKC Activation and p47phox Phosphorylation by PP2A , 2018, Molecular Neurobiology.

[15]  D. Krainc,et al.  Synaptic, Mitochondrial, and Lysosomal Dysfunction in Parkinson’s Disease , 2019, Trends in Neurosciences.

[16]  S. Pan,et al.  A Modified Technique for Culturing Primary Fetal Rat Cortical Neurons , 2012, Journal of biomedicine & biotechnology.

[17]  G. Deuschl,et al.  MDS clinical diagnostic criteria for Parkinson's disease , 2015, Movement disorders : official journal of the Movement Disorder Society.

[18]  S. Horvath,et al.  Parkinson’s disease is associated with DNA methylation levels in human blood and saliva , 2017, Genome Medicine.

[19]  Hamed S. Hayatshahi,et al.  Analogues of Arylamide Phenylpiperazine Ligands To Investigate the Factors Influencing D3 Dopamine Receptor Bitropic Binding and Receptor Subtype Selectivity. , 2018, ACS chemical neuroscience.

[20]  Brad T. Sherman,et al.  Bioinformatics enrichment tools: paths toward the comprehensive functional analysis of large gene lists , 2008, Nucleic acids research.

[21]  T. Bottiglieri,et al.  Acute Administration of l-Dopa Induces Changes in Methylation Metabolites, Reduced Protein Phosphatase 2A Methylation, and Hyperphosphorylation of Tau Protein in Mouse Brain , 2012, The Journal of Neuroscience.

[22]  Francisco Tirado,et al.  MARQ: an online tool to mine GEO for experiments with similar or opposite gene expression signatures , 2010, Nucleic Acids Res..

[23]  T. Dawson,et al.  Trumping neurodegeneration: Targeting common pathways regulated by autosomal recessive Parkinson's disease genes , 2017, Experimental Neurology.

[24]  Dongmei Wang,et al.  Mitochondrial Creatine Kinase is Decreased in the Serum of Idiopathic Parkinson’s Disease Patients , 2019, Aging and disease.

[25]  Zhang Zhang,et al.  Biological Databases for Human Research , 2015, Genom. Proteom. Bioinform..

[26]  M. T. Pellecchia,et al.  Alteration of endosomal trafficking is associated with early-onset parkinsonism caused by SYNJ1 mutations , 2018, Cell Death & Disease.

[27]  Yan Lin,et al.  An R package suite for microarray meta-analysis in quality control, differentially expressed gene analysis and pathway enrichment detection , 2012, Bioinform..

[28]  P. De Camilli,et al.  Regulation of postsynaptic AMPA responses by synaptojanin 1 , 2008, Proceedings of the National Academy of Sciences.

[29]  A. Puschmann.  New Genes Causing Hereditary Parkinson’s Disease or Parkinsonism , 2017, Current Neurology and Neuroscience Reports.

[30]  Murray Grossman,et al.  Clinical diagnosis of progressive supranuclear palsy: The movement disorder society criteria , 2017, Movement disorders : official journal of the Movement Disorder Society.

[31]  Jing Yang,et al.  Causes of Death in Chinese Patients with Multiple System Atrophy , 2018, Aging and disease.

[32]  M. Mumby.  PP2A: Unveiling a Reluctant Tumor Suppressor , 2007, Cell.

[33]  Y. Asmann,et al.  ApoE (Apolipoprotein E) in Brain Pericytes Regulates Endothelial Function in an Isoform-Dependent Manner by Modulating Basement Membrane Components. , 2019, Arteriosclerosis, thrombosis, and vascular biology.

[34]  P. Hof,et al.  Parkinson's Disease-Associated LRRK2 Hyperactive Kinase Mutant Disrupts Synaptic Vesicle Trafficking in Ventral Midbrain Neurons , 2017, The Journal of Neuroscience.